Chiesi Hellas

Pressurised inhalation solution containing Budesonide 200 mcg/dose.

Διάλυμα για εισπνοή υπό πίεση με δραστική ουσία τη βουδεσονίδη.

Εναιώρημα για εισπνοή με εκνεφωτή περιέχον βεκλομεθαζόνη (μπεκλομεθαζόνη).

Fixed combination inhaler containing beclometasone dipropionate and formoterol fumarate in a pressurized metered-dose inhaler format for asthma maintenance and MART therapy, as well as COPD.

Pressurised inhalation solution containing Beclometasone dipropionate anhydrous and Formoterol fumarate dihydrate.

Dry powder inhaler formulation containing beclometasone dipropionate and formoterol fumarate for the maintenance treatment of asthma and COPD.

Modulite-based pMDI spray containing formoterol fumarate as a long-acting beta-2 agonist for long-term bronchodilator therapy in asthma and symptom relief in COPD.

Beclospin 400 micrograms nebuliser suspension containing beclometasone dipropionate for inhalation via a nebuliser, indicated for asthma treatment and recurrent wheezing.

Beclospin 800 micrograms nebuliser suspension containing beclometasone dipropionate for inhalation via a nebuliser, indicated for asthma treatment and recurrent wheezing.

Fixed combination of beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium bromide indicated as a maintenance treatment in adult patients with moderate to severe COPD.

Διάλυμα για εισπνοή υπό πίεση (υγρό για εισπνοή υπό πίεση) που περιέχει διπροπιονική βεκλομεθαζόνη, διυδρική φουμαρική φορμοτερόλη και γλυκοπυρρόνιο ανά παρεχόμενη δόση.

Caffeine citrate solution indicated for the treatment of primary apnoea in preterm neonates, administered by slow intravenous infusion or orally.

Peyona 20 mg/ml is a pharmaceutical product listed under the rare diseases product portfolio.

An inhalation powder containing beclometasone dipropionate anhydrous and formoterol fumarate dihydrate.

Hypertonic solution for inhalation containing sodium chloride and sodium hyaluronate to facilitate the mobilization of viscous airway secretions via an osmotic mechanism. Particularly indicated in patients with cystic fibrosis and bronchiectasis.

Natural pulmonary surfactant prepared from porcine lungs containing polar lipids and hydrophobic low molecular weight specific proteins SP-B and SP-C, indicated for the treatment and prevention of respiratory distress syndrome (RDS) in premature newborns.

Pressurised inhalation solution containing Formoterol Fumarate Dihydrate + Beclomethasone Dipropionate (100+6) mcg/dose.

THERA-PEARL Pals animals hot and cold pack designed to deliver soothing relief for children's minor accidents, bumps, and bruises.

Bramitob 300 mg/4 ml inhalation solution containing tobramycin, an aminoglycoside antibiotic used for the treatment of chronic chest infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.

VIVACE combination tablet formulation containing (30+10)mg/tab.

Lamzede contains the active substance velmanase alfa, an enzyme replacement therapy used for the treatment of non-neurological symptoms in patients with mild to moderate alpha-mannosidosis.

Kengrexal is an antiplatelet medicine containing the active substance cangrelor, used to reduce blood clot formation during percutaneous coronary intervention (PCI).

BREXIN contains piroxicam beta-cyclodextrin and belongs to a class of medicines called Non-Steroidal Anti-inflammatory Drugs (NSAIDs), used against pain, fever, and inflammation.

Elfabrio is an enzyme replacement therapy containing pegunigalsidase alfa used for the long-term treatment of adults with confirmed Fabry disease.

VIVACE is a combination of two active ingredients, delapril hydrochloride and manidipine hydrochloride, used for the treatment of high blood pressure (hypertension) in adult patients whose blood pressure is not adequately controlled by either substance alone.